Alnylam Pharmaceuticals, Inc.
Close on Nov 18, 2026Market cap $20.01BP/E 7.8Yield –
Alnylam Pharmaceuticals CEO Total Annual Compensation by Year
CEO Total Annual Compensation (DEF 14A Pay Ratio Disclosure, $) ($)
Alnylam Pharmaceuticals CEO Total Annual Compensation: $14,867,600 in FY2025, up 29.4% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
“We calculated the 2025 compensation for our median employee of $312,180 in the same manner we determine the annual total compensation of our NEOs for purposes of the Summary Compensation Table. Dr. Greenstreet’s 2025 compensation as disclosed in the Summary Compensation Table is $14,867,600. As a result, our CEO to median employee pay ratio for 2025 is 48:1”
Source: Alnylam Form DEF 14A (2026 Proxy Statement (DEF 14A), filed 2026-04-06) ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CEO Total Annual Compensation (DEF 14A Pay Ratio Disclosure, $) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14,867,600 | +29.4% | Alnylam Form DEF 14A (2026 Proxy Statement (DEF 14A), filed 2026-04-06) ↗ |
| FY2024 | Dec 31, 2024 | 11,492,970 | +29.2% | Alnylam Form DEF 14A (2025 Proxy Statement (DEF 14A), filed 2025-03-24) ↗ |
| FY2023 | Dec 31, 2023 | 8,895,670 | +93.9% | Alnylam Form DEF 14A (2024 Proxy Statement (DEF 14A), filed 2024-04-01) ↗ |
| FY2022 | Dec 31, 2022 | 4,588,810 | -54.9% | Alnylam Form DEF 14A (2023 Proxy Statement (DEF 14A), filed 2023-04-03) ↗ |
| FY2021 | Dec 31, 2021 | 10,176,685 | +30.2% | Alnylam Form DEF 14A (2022 Proxy Statement (DEF 14A), filed 2022-04-05) ↗ |
| FY2020 | Dec 31, 2020 | 7,818,164 | +6.8% | Alnylam Form DEF 14A (2021 Proxy Statement (DEF 14A), filed 2021-04-02) ↗ |
| FY2019 | Dec 31, 2019 | 7,317,856 | +43.8% | Alnylam Form DEF 14A (2020 Proxy Statement (DEF 14A), filed 2020-03-23) ↗ |
| FY2018 | Dec 31, 2018 | 5,089,269 | – | Alnylam Form DEF 14A (2019 Proxy Statement (DEF 14A), filed 2019-03-21) ↗ |
Cite this data
StockData. (2026). Alnylam Pharmaceuticals CEO Total Annual Compensation ($), annual FY2018–FY2025 [Data set]. Compiled from Alnylam Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/alny/kpis/proxy-ceo-total-comp
See every metric in the Alnylam Pharmaceuticals KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?